Hot stocks: Bet on Dr Lal PathLabs, Bharat Dynamics, DLF for short term
DLF stock is demonstrating a bullish trend, consistently forming higher highs and higher lows.31-01-2024
31-01-2024
Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
In continuation to our letter dated December 26, 2023 and in line with the provisions of the SEBI (PIT) Regulation, 2015 and company''s code for prevention of insider trading, the trading window for dealing in securities of the company is closed and shall re-open after 48 hours from declaration of Financial Results for the Quarter and Nine Months ended December 31, 2023.25-01-2024
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Thursday, February 01, 2024 at 5:00 P.M. (IST) to discuss the financial and operating performance for Q3 & 9M FY24.25-01-2024
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for Approval Of The Un-Audited (Standalone & Consolidated) Financial Results For The Quarter And Nine Months Ended December 31, 2023 And To Consider The Proposal Of 2Nd Interim Dividend, If Any
Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 ,inter alia, to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the Quarter and Nine Months ended December 31, 2023 and declaration of 2nd interim dividend, if any, on the equity shares of the Company for the Financial Year 2023-24.25-01-2024
Dr. Lal PathLabs Ltd - 539524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 201808-01-2024
Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
Intimation of Closure of Trading Window26-12-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meeting14-12-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meeting28-11-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication wrt. Notice to Equity Shareholders regarding unclaimed Equity Share due for transfer to IEPF23-11-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 8000 equity shares through Circulation pursuant to ESOP Plan of the Company17-11-2023